SAO PAULO (AP) — Former Brazilian President Jair Bolsonaro 's kidney function worsened at the intensive care unit to which he ...
With a fresh phase 3 win for Kerendia, Bayer is one step closer to pushing the ascendant drug into a much broader population ...
An interdisciplinary team from the University Hospitals Cologne and Bonn have conducted the first prospective study to ...
Surprisingly, his heart health, cholesterol and blood pressure are always great when tested.
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
Jair Bolsonaro's kidney function shows improvement, but he remains in intensive care due to pneumonia as he serves a 27-year ...
Kerendia has hit the spot in another phase 3 trial that could extend its use as a treatment for patients with chronic kidney disease (CKD). Extending the label for Kerendia is a strategic priority for ...
Chronic kidney disease (CKD) affects nearly 36 million people. “CKD is a real public health crisis, and one that’s steadily rising,” said Merlin Thomas, M.B.Ch.B., Ph.D., FRACP, a professor of ...
Shannon’s husband, Kyle, immediately volunteered to begin testing as a potential living donor — not just for her, but for ...
Frequent UTIs shouldn’t be taken lightly. They may indicate a bigger problem. A top doctor explained their symptoms, causes, ...